Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 420.59M | 423.30M | 284.63M | 276.61M | 338.82M |
| Total Receivables | 345.15M | 347.37M | 380.12M | 369.40M | 337.66M |
| Inventory | 103.76M | 104.43M | 108.61M | 105.55M | 113.85M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.69M | 13.77M | 21.88M | 21.26M | 21.76M |
| Total Current Assets | 883.19M | 888.87M | 795.24M | 772.82M | 812.09M |
|
|
|||||
| Total Current Assets | 883.19M | 888.87M | 795.24M | 772.82M | 812.09M |
| Net Property, Plant & Equipment | 309.21M | 311.19M | 306.07M | 297.45M | 295.46M |
| Long-term Investments | 19.61M | 19.73M | 20.09M | 19.53M | 19.65M |
| Goodwill | 19.61M | 19.73M | 20.09M | 19.53M | 19.65M |
| Total Other Intangibles | 131.21M | 132.05M | 100.94M | 98.10M | 75.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 71.09M | 71.55M | 85.50M | 83.09M | 57.49M |
| Total Assets | 1.61B | 1.62B | 1.53B | 1.49B | 1.75B |
|
|
|||||
| Total Accounts Payable | 48.98M | 49.29M | 44.74M | 43.47M | 63.04M |
| Total Accrued Expenses | 123.16M | 123.95M | 147.44M | 143.29M | 130.96M |
| Short-term Debt | 136.75M | 137.63M | 107.52M | 104.49M | 62.03M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.63M | 11.71M | 46.90M | 45.58M | 12.11M |
| Total Finance Division Other Current Liabilities | 100.15M | 100.80M | 32.18M | 31.28M | 77.30M |
| Total Other Current Liabilities | 100.15M | 100.80M | 32.18M | 31.28M | 77.30M |
| Total Current Liabilities | 420.68M | 423.38M | 378.78M | 368.10M | 345.44M |
|
|
|||||
| Total Current Liabilities | 420.68M | 423.38M | 378.78M | 368.10M | 345.44M |
| Long-Term Debt | 1.17M | 1.18M | 29.03M | 28.21M | 62.05M |
| Short-term Debt | 136.75M | 137.63M | 107.52M | 104.49M | 62.03M |
| Capital Leases | 13.08M | 13.16M | 18.11M | 17.60M | 23.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 226.21M | 227.66M | 86.14M | 83.71M | 70.65M |
| Total Liabilities | 661.14M | 665.39M | 512.06M | 497.62M | 501.41M |
|
|
|||||
| Common Stock & APIC | 436.75M | 439.55M | 447.59M | 434.97M | 426.71M |
| Retained Earnings | 480.36M | 483.44M | 541.16M | 525.91M | 777.96M |
| Treasury Stock & Other | 33.61M | 33.82M | 29.84M | 29.00M | 43.66M |
| Total Common Equity | 950.71M | 956.82M | 1.02B | 989.88M | 1.25B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 950.71M | 956.82M | 1.02B | 989.88M | 1.25B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 950.71M | 956.82M | 1.02B | 989.88M | 1.25B |
|
|
|||||